ILD/CVID/GD | Sarcoid controls | p-value | |
Subjects | 20 | 57 | |
Nodules | 16 (80) | 24 (42) | 0.004 |
Halo sign | 6 (30) | 2 (3.5) | 0.003 |
Micronodules | 12 (60) | 45 (79) | 0.1 |
Distribution | <0.001 | ||
Perilymphatic | 5 (42) | 45 (100) | |
Random | 7 (58) | 0 (0) | |
Lines | 13 (65) | 33 (58) | 0.58 |
Ground glass | 8 (40) | 27 (47) | 0.57 |
Airspace consolidation | 5 (25) | 24 (42) | 0.19 |
Bronchiectasis | 13 (65) | 13 (23) | <0.001 |
Bronchial wall thickening | 9 (45) | 33 (58) | 0.32 |
Mediastinal lymph nodes | 14 (70) | 41 (72) | 0.87 |
Hilar lymph nodes, | 7 (35) | 39 (68) | 0.009 |
Main CT pattern | 0.003 | ||
Nodules | 6 | 5 | |
Micronodules | 5 | 20 | |
Ground glass | 1 | 15 | |
Lines | 4 | 3 | |
Consolidation | 0 | 9 | |
Miscellaneous# | 4 | 5 |
Data are presented as n or n (%), unless otherwise stated. #: lines/ground glass (three versus one), nodules/ground glass (one versus none) and bronchial wall thickening (none versus four). Bold indicates statistically significant p-values.